An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice

William L. Holland, Andrew C. Adams, Joseph T. Brozinick, Hai H. Bui, Yukiko Miyauchi, Christine M. Kusminski, Steven M. Bauer, Mark Wade, Esha Singhal, Christine C. Cheng, Katherine Volk, Ming Shang Kuo, Ruth Gordillo, Alexei Kharitonenkov, Philipp E. Scherer

Research output: Contribution to journalArticle

248 Citations (Scopus)

Abstract

FGF21, a member of the fibroblast growth factor (FGF) superfamily, has recently emerged as a regulator of metabolism and energy utilization. However, the exact mechanism(s) whereby FGF21 mediates its actions have not been elucidated. There is considerable evidence that insulin resistance may arise from aberrant accumulation of intracellular lipids in insulin-responsive tissues due to lipotoxicity. In particular, the sphingolipid ceramide has been implicated in this process. Here, we show that FGF21 rapidly and robustly stimulates adiponectin secretion in rodents while diminishing accumulation of ceramides in obese animals. Importantly, adiponectin-knockout mice are refractory to changes in energy expenditure and ceramide-lowering effects evoked by FGF21 administration. Moreover, FGF21 lowers blood glucose levels and enhances insulin sensitivity in diabetic Lepob/ob mice and diet-induced obese (DIO) mice only when adiponectin is functionally present. Collectively, these data suggest that FGF21 is a potent regulator of adiponectin secretion and that FGF21 critically depends on adiponectin to exert its glycemic and insulin sensitizing effects.

Original languageEnglish (US)
Pages (from-to)790-797
Number of pages8
JournalCell Metabolism
Volume17
Issue number5
DOIs
StatePublished - May 7 2013

Fingerprint

Ceramides
Adiponectin
Energy Metabolism
Insulin
Insulin Resistance
Obese Mice
Sphingolipids
Fibroblast Growth Factors
fibroblast growth factor 21
Knockout Mice
Blood Glucose
Rodentia
Diet
Lipids

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Physiology

Cite this

An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. / Holland, William L.; Adams, Andrew C.; Brozinick, Joseph T.; Bui, Hai H.; Miyauchi, Yukiko; Kusminski, Christine M.; Bauer, Steven M.; Wade, Mark; Singhal, Esha; Cheng, Christine C.; Volk, Katherine; Kuo, Ming Shang; Gordillo, Ruth; Kharitonenkov, Alexei; Scherer, Philipp E.

In: Cell Metabolism, Vol. 17, No. 5, 07.05.2013, p. 790-797.

Research output: Contribution to journalArticle

Holland, WL, Adams, AC, Brozinick, JT, Bui, HH, Miyauchi, Y, Kusminski, CM, Bauer, SM, Wade, M, Singhal, E, Cheng, CC, Volk, K, Kuo, MS, Gordillo, R, Kharitonenkov, A & Scherer, PE 2013, 'An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice', Cell Metabolism, vol. 17, no. 5, pp. 790-797. https://doi.org/10.1016/j.cmet.2013.03.019
Holland, William L. ; Adams, Andrew C. ; Brozinick, Joseph T. ; Bui, Hai H. ; Miyauchi, Yukiko ; Kusminski, Christine M. ; Bauer, Steven M. ; Wade, Mark ; Singhal, Esha ; Cheng, Christine C. ; Volk, Katherine ; Kuo, Ming Shang ; Gordillo, Ruth ; Kharitonenkov, Alexei ; Scherer, Philipp E. / An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. In: Cell Metabolism. 2013 ; Vol. 17, No. 5. pp. 790-797.
@article{c622b72b56f64cc7ab8514ebd759eca1,
title = "An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice",
abstract = "FGF21, a member of the fibroblast growth factor (FGF) superfamily, has recently emerged as a regulator of metabolism and energy utilization. However, the exact mechanism(s) whereby FGF21 mediates its actions have not been elucidated. There is considerable evidence that insulin resistance may arise from aberrant accumulation of intracellular lipids in insulin-responsive tissues due to lipotoxicity. In particular, the sphingolipid ceramide has been implicated in this process. Here, we show that FGF21 rapidly and robustly stimulates adiponectin secretion in rodents while diminishing accumulation of ceramides in obese animals. Importantly, adiponectin-knockout mice are refractory to changes in energy expenditure and ceramide-lowering effects evoked by FGF21 administration. Moreover, FGF21 lowers blood glucose levels and enhances insulin sensitivity in diabetic Lepob/ob mice and diet-induced obese (DIO) mice only when adiponectin is functionally present. Collectively, these data suggest that FGF21 is a potent regulator of adiponectin secretion and that FGF21 critically depends on adiponectin to exert its glycemic and insulin sensitizing effects.",
author = "Holland, {William L.} and Adams, {Andrew C.} and Brozinick, {Joseph T.} and Bui, {Hai H.} and Yukiko Miyauchi and Kusminski, {Christine M.} and Bauer, {Steven M.} and Mark Wade and Esha Singhal and Cheng, {Christine C.} and Katherine Volk and Kuo, {Ming Shang} and Ruth Gordillo and Alexei Kharitonenkov and Scherer, {Philipp E.}",
year = "2013",
month = "5",
day = "7",
doi = "10.1016/j.cmet.2013.03.019",
language = "English (US)",
volume = "17",
pages = "790--797",
journal = "Cell Metabolism",
issn = "1550-4131",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice

AU - Holland, William L.

AU - Adams, Andrew C.

AU - Brozinick, Joseph T.

AU - Bui, Hai H.

AU - Miyauchi, Yukiko

AU - Kusminski, Christine M.

AU - Bauer, Steven M.

AU - Wade, Mark

AU - Singhal, Esha

AU - Cheng, Christine C.

AU - Volk, Katherine

AU - Kuo, Ming Shang

AU - Gordillo, Ruth

AU - Kharitonenkov, Alexei

AU - Scherer, Philipp E.

PY - 2013/5/7

Y1 - 2013/5/7

N2 - FGF21, a member of the fibroblast growth factor (FGF) superfamily, has recently emerged as a regulator of metabolism and energy utilization. However, the exact mechanism(s) whereby FGF21 mediates its actions have not been elucidated. There is considerable evidence that insulin resistance may arise from aberrant accumulation of intracellular lipids in insulin-responsive tissues due to lipotoxicity. In particular, the sphingolipid ceramide has been implicated in this process. Here, we show that FGF21 rapidly and robustly stimulates adiponectin secretion in rodents while diminishing accumulation of ceramides in obese animals. Importantly, adiponectin-knockout mice are refractory to changes in energy expenditure and ceramide-lowering effects evoked by FGF21 administration. Moreover, FGF21 lowers blood glucose levels and enhances insulin sensitivity in diabetic Lepob/ob mice and diet-induced obese (DIO) mice only when adiponectin is functionally present. Collectively, these data suggest that FGF21 is a potent regulator of adiponectin secretion and that FGF21 critically depends on adiponectin to exert its glycemic and insulin sensitizing effects.

AB - FGF21, a member of the fibroblast growth factor (FGF) superfamily, has recently emerged as a regulator of metabolism and energy utilization. However, the exact mechanism(s) whereby FGF21 mediates its actions have not been elucidated. There is considerable evidence that insulin resistance may arise from aberrant accumulation of intracellular lipids in insulin-responsive tissues due to lipotoxicity. In particular, the sphingolipid ceramide has been implicated in this process. Here, we show that FGF21 rapidly and robustly stimulates adiponectin secretion in rodents while diminishing accumulation of ceramides in obese animals. Importantly, adiponectin-knockout mice are refractory to changes in energy expenditure and ceramide-lowering effects evoked by FGF21 administration. Moreover, FGF21 lowers blood glucose levels and enhances insulin sensitivity in diabetic Lepob/ob mice and diet-induced obese (DIO) mice only when adiponectin is functionally present. Collectively, these data suggest that FGF21 is a potent regulator of adiponectin secretion and that FGF21 critically depends on adiponectin to exert its glycemic and insulin sensitizing effects.

UR - http://www.scopus.com/inward/record.url?scp=84877272187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877272187&partnerID=8YFLogxK

U2 - 10.1016/j.cmet.2013.03.019

DO - 10.1016/j.cmet.2013.03.019

M3 - Article

VL - 17

SP - 790

EP - 797

JO - Cell Metabolism

JF - Cell Metabolism

SN - 1550-4131

IS - 5

ER -